Smillie Fiona, Glinka Weronika, Henry Christopher, McCudden Adam, Thorpe Jennifer, Holman Stephen W
Early Product Development & Manufacturing, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Macclesfield, UK.
Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
Drug Test Anal. 2025 Jul;17(7):1096-1106. doi: 10.1002/dta.3816. Epub 2024 Oct 12.
Counterfeit pharmaceuticals are a subclass of falsified and substandard medicines. They are illicit products, purporting to be genuine medicines, that are made and sold by criminal organisations. They represent a significant risk to patient safety, as well as a financial and reputational threat to the companies who make the genuine medicines. It is essential to have analytical methods to determine if suspect samples seized by law enforcement agencies are counterfeit, with mass spectrometry (MS) being a commonly used technique in forensic cases. Speed-to-answer is vital to enable law enforcement agencies to progress investigations, as well as for pharmaceutical companies so that they can notify health authorities of the circulation of counterfeit medicines. In this work, an atmospheric solids analysis probe (ASAP)-MS was assessed as a fast and simple-to-use approach to analyse tablets on a commercially available instrument. Complementing the analytics with real-time sample recognition software demonstrated that the classification of tablets as authentic or counterfeit could be achieved quickly (< 2 min) and without the need for MS interpretation skills. Authentication of five tablets (two authentic pharmaceuticals, one placebo and two counterfeits containing the correct active pharmaceutical ingredient [API] but at lower quantities than in the genuine medicine and with different excipient contents) of unknown origin was achieved with 100% success. This creates the opportunity to deploy the end-to-end workflow as a tool for non-scientists, such as law enforcement officers and border control staff, for use in-territory to obtain fast answers and make data-led decisions to control the illegal trading of medicines.
假冒药品是伪造和不合格药品的一个子类。它们是非法产品,冒充正品药品,由犯罪组织制造和销售。它们对患者安全构成重大风险,同时也对生产正品药品的公司构成财务和声誉威胁。拥有分析方法以确定执法机构查获的可疑样品是否为假冒药品至关重要,质谱法(MS)是法医案件中常用的技术。快速给出答案对于执法机构推进调查以及制药公司通知卫生当局假冒药品的流通情况至关重要。在这项工作中,对一种常压固体分析探头(ASAP)-MS进行了评估,它是一种在商用仪器上分析片剂的快速且易于使用的方法。用实时样品识别软件对分析进行补充表明,可以快速(<2分钟)实现片剂真伪的分类,且无需质谱解释技能。对五片来源不明的片剂(两片正品药品、一片安慰剂以及两片含有正确活性药物成分[API]但含量低于正品且辅料成分不同的假冒品)进行真伪鉴定,成功率达到了100%。这为将端到端工作流程作为一种工具部署给非专业人员(如执法人员和边境管制人员)创造了机会,以便他们在当地使用,快速获得答案并做出基于数据的决策,以控制药品的非法交易。